In a high-fat diet-induced NAFLD model, EGCG was found to promote insulin clearance in hepatocytes and improve cellular sensitivity to insulin by upregulating the expression of insulin-degrading enzyme (IDE). This evidence concerns the gene IDE and metabolic dysfunction-associated steatotic liver disease.